Elevance Health Inc’s recent filing unveils that its EVP & President, Commercial Kendrick Charles Morgan JR unloaded Company’s shares for reported $3.21 million on Oct 18 ’24. In the deal valued at $432.14 per share,7,417 shares were sold. As a result of this transaction, Kendrick Charles Morgan JR now holds 8,423 shares worth roughly $3.33 million.
Then, Kendrick Charles Morgan JR bought 7,417 shares, generating $3,206,221 in total proceeds.
Before that, PERU RAMIRO G sold 753 shares. Elevance Health Inc shares valued at $400,235 were divested by the Director at a price of $531.52 per share. As a result of the transaction, PERU RAMIRO G now holds 8,744 shares, worth roughly $3.46 million.
Stephens downgraded its Elevance Health Inc [ELV] rating to an Equal-weight from a an Overweight in a research note published on January 22, 2025; the price target was decreased to $440 from $520. A number of analysts have revised their coverage, including Argus’s analysts, who decreased its forecast for the stock in mid October from “a Buy” to “a Hold”. BofA Securities also remained covering ELV and has decreased its forecast on July 18, 2024 with a “Neutral” recommendation from previously “Buy” rating. Morgan Stanley started covering the stock on June 24, 2024. It rated ELV as “an Overweight”.
Price Performance Review of ELV
On Monday, Elevance Health Inc [NYSE:ELV] saw its stock fall -0.35% to $395.50. Over the last five days, the stock has gained 2.66%. Elevance Health Inc shares have risen nearly 7.21% since the year began. Nevertheless, the stocks have fallen -21.39% over the past one year. While a 52-week high of $567.26 was reached on 01/27/25, a 52-week low of $362.21 was recorded on 01/02/25. SMA at 50 days reached $387.01, while 200 days put it at $468.84.
Levels Of Support And Resistance For ELV Stock
The 24-hour chart illustrates a support level at 392.38, which if violated will result in even more drops to 389.26. On the upside, there is a resistance level at 401.02. A further resistance level may holdings at 406.54. The Relative Strength Index (RSI) on the 14-day chart is 52.31, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.65, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 31.16%. Stochastics %K at 67.66% indicates the stock is a holding.
The most recent change occurred on May 30, 2024 when Robert W. Baird began covering the stock and recommended ‘”an Outperform”‘ rating along with a $649 price target.
